Pindolol in schizophrenia
O'Connor, M.
Medical Journal of Australia 1(8): 429
1981
ISSN/ISBN: 0025-729X PMID: 7254092 Document Number: 169972
Document emailed within 1 workday
Related Documents
De Micheli, A.; Cordera, R.; Maiello, M.; Odetti, P.; Viviani, G.; Boeri, D.; Prando, R. 1979: Effects of pindolol on insulin secretion. I. Insulin response to small intravenous loads of glucose and to pindolol infusion Minerva Dietologica E Gastroenterologica 25(3): 297-304Schooler, N.R.; Keith, S.J.; Severe, J.B.; Matthews, S. 1989: Acute treatment response and short term outcome in schizophrenia: first results of the NIMH treatment strategies in schizophrenia study. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 331-335
Roxo, H. 1952: Pseudoneurotics; patients at the onset of schizophrenia; differential diagnosis of neurasthenia and schizophrenia; modern therapy Imprensa Medica 28(463): 25-30
Zaytseva, Y.; Burova, V.; Garakh, Z.; Gurovich, I.Y. 2013: Attributional style in fist episode of schizophrenia and schizophrenia spectrum disorders with and without paranoid ideation Psychiatria Danubina 25(Suppl 2): S329-S331
Tsirkin, S.Iu. 1987: International study of schizophrenia based on a WHO program. Incidence of schizophrenia Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 87(8): 1203-1207
Kotlicka-Antczak, M.; Rabe-Jabłońska, J. 1997: Neurodevelopmental schizophrenia: the concept of developmental origins of certain forms of schizophrenia Psychiatria Polska 31(5): 527-538
Arraras, J.I.; Basterra, I.; Pereda, N.; Ibañez, B.; Iribarren, S.; Cabases, J.M. 2019: The Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) questionnaire. A validation study with Spanish schizophrenia spectrum outpatients Actas Espanolas de Psiquiatria 47(3): 97-109
Suzuki, S. 1982: The mental maturation and verbal alteration in a mild case of chronic non-paranoiac schizophrenia. a linguistic-phenomenological approach to the concept of schizophrenia simplex Seishin Shinkeigaku Zasshi 84(1): 1-19
Marcelle, R.; Juchmés, J.; Lecomte, J. 1981: Possible bronchomotor effects of pindolol Revue Medicale de Liege 36(5): 204-208
Dupuis, C.; Breviere, G.M. 1973: Value of pindolol in cyanotic congenital cardiopathies Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 18(7): 828-831
Juillard, A.; Guenver, P.; Bruneval, P.; Barrillon, A.; Gerbaux, A. 1981: Electrophysiological exploration during intoxication by pindolol Annales de Cardiologie et d'Angeiologie 30(6): 403-406
Frithz, G. 1975: Pindolol once daily in the treatment of hypertension Lakartidningen 72(33): 3073-3074
Strozzi, C.; Cocco, G. 1978: Pindolol in the treatment of arterial hypertension Minerva Medica 69(4): 247-256
Schell, E.; Görlich, W.; Lang, E. 1986: Pindolol eyedrops: does ISA provide more cardiac safety? Medizinische Klinik 81(10): 349-350
Benyamine, R.; Jouve, A. 1972: Treatment of chronic coronary insufficiency with pindolol Marseille Medical 109(1): 91-94
Gruppillo, P.; Padovan, G.C.; Masoni, C.; Tomaini, M.D. 1982: Use of pindolol in a once-a-day dose in the treatment of arterial hypertension La Clinica Terapeutica 100(2): 167-174
Mohamed, M.E.; Tawakkol, M.S.; Aboul-Enein, H.Y. 1983: Spectrofluorometric determination of pindolol and its dosage form Journal - Association of Official Analytical Chemists 66(2): 273-275
Giordano, A.; Tamiz, A.; Schiavo, B.; Rossi, P. 1979: Pindolol in the treatment of arrhythmias caused by exertion Minerva Medica 70(51): 3499-3501
Hargreaves, W.A.; Kane, J.M.; Ninan, P.T.; Severe, J.B.; Woerner, M. 1989: Demographic characteristics, treatment history, presenting psychopathology and early course in schizophrenia. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 340-343
Hasegawa, R.; Kushiya, M.; Komuro, T.; Isaka, H. 1987: Stereoselective determination of racemic pindolol in rat plasma and its application Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 1987(105): 71-73